ClinicalTrials.govpublic full text
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
secondary (aa) amyloidosis, rheumatoid arthritis, nephrotic syndrome, familial mediterranean syndrome, kidney diseases, gastrointestinal diseases, familial mediterranean fever, amyloidosis, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 869353
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.